CLPT
ClearPoint Neuro, Inc.
NASDAQHealthcareMedical - DevicesUS
Rating:D+
Company Profile
CEO
Joseph Michael Burnett
IPO Date
2012-05-22
Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Country
US
ClearPoint Neuro, Inc.
CEO
Joseph Michael Burnett
IPO Date
2012-05-22
Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Country
US
| 222 |
| $17.84 |
| 2 Jul 2026 | STIGALL L. JEREMY | Chief Business Officer | A-Award | Acquired | 1,781 | $11.93 |
| 2 Jul 2026 | D'Alessandro Danilo | Chief Financial Officer | A-Award | Acquired | 1,085 | $11.93 |
| 2 Jul 2026 | BURNETT JOSEPH | director, officer: CEO and President | A-Award | Acquired | 1,361 | $11.93 |
| 1 Jul 2026 | BURNETT JOSEPH | director, officer: CEO and President | M-Exempt | Acquired | 20,000 | $2.50 |
| 1 Jul 2026 | BURNETT JOSEPH | director, officer: CEO and President | S-Sale | Disposed | 20,000 | $19.38 |
| 1 Jul 2026 | BURNETT JOSEPH | director, officer: CEO and President | M-Exempt | Disposed | 20,000 | $2.50 |
| 22 Jun 2026 | BURNETT JOSEPH | director, officer: CEO and President | M-Exempt | Acquired | 60,000 | $2.50 |
| 22 Jun 2026 | BURNETT JOSEPH | director, officer: CEO and President | S-Sale | Disposed | 60,000 | $17.79 |